Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia

Journal of Immunology

Volumn 193, Issue 9, 2014, Pages 4457-4468

  Martinez, Nuria ^a   Vallerskog, Therese ^a   West, Kim ^a   Nunes Alves, Claudio ^a   Lee, Jinhee ^a   Martens, Gregory W ^a   Behar, Samuel M ^a   Kornfeld, Hardy ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CHROMATIN; CYTOKINE; IMMUNOGLOBULIN RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CHROMATIN; CHROMATIN DECONDENSATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; ENZYME INHIBITION; EPIGENETICS; HYPERGLYCEMIA; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; ANTIGEN PRESENTING CELL; BIOSYNTHESIS; BONE MARROW CELL; DISEASE MODEL; GENE EXPRESSION; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; BONE MARROW CELLS; CHROMATIN; CYTOKINES; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; HYPERGLYCEMIA; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 84908123157     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401125     Document Type: Article

References (44)

1. Mathers, C. D., and D. Loncar. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3: e442.
2. Brownlee, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
3. Koh, G. C., S. J. Peacock, T. van der Poll, and W. J. Wiersinga. 2012. The impact of diabetes on the pathogenesis of sepsis. Eur. J. Clin. Microbiol. Infect. Dis. 31: 379-388.
4. Martens, G. W., M. C. Arikan, J. Lee, F. Ren, D. Greiner, and H. Kornfeld. 2007. Tuberculosis susceptibility of diabetic mice. Am. J. Respir. Cell Mol. Biol. 37: 518-524.
5. Kumar, N. P., R. Sridhar, V. V. Banurekha, M. S. Jawahar, M. P. Fay, T. B. Nutman, and S. Babu. 2013. Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines. Ann. Am. Thorac. Soc. 10: 441-449.
6. Kumar, N. P., R. Sridhar, V. V. Banurekha, M. S. Jawahar, T. B. Nutman, and S. Babu. 2013. Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J. Infect. Dis. 208: 739-748.
7. Restrepo, B. I., S. P. Fisher-Hoch, P. A. Pino, A. Salinas, M. H. Rahbar, F. Mora, N. Cortes-Penfield, and J. B. McCormick. 2008. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin. Infect. Dis. 47: 634-641.
8. Vallerskog, T., G. W. Martens, and H. Kornfeld. 2010. Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J. Immunol. 184: 6275-6282.
9. Volz, H. C., C. Seidel, D. Laohachewin, Z. Kaya, O. J. Müller, S. T. Pleger, F. Lasitschka, M. E. Bianchi, A. Remppis, A. Bierhaus, et al. 2010. HMGB1: the missing link between diabetes mellitus and heart failure. Basic Res. Cardiol. 105: 805-820.
10. Yao, D., and M. Brownlee. 2010. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 59: 249-255.
11. + effector and central memory T cells. Nat. Immunol. 12: 467-471.
12. Rudd, C. E. 2005. MAPK p38: alternative and nonstressful in T cells. Nat. Immunol. 6: 368-370.
13. Jirmanova, L., M. L. Giardino Torchia, N. D. Sarma, P. R. Mittelstadt, and J. D. Ashwell. 2011. Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation. Blood 118: 3280-3289.
14. Newton, R. H., and L. A. Turka. 2012. Regulation of T cell homeostasis and responses by pten. Front. Immunol. 3: 151.
15. Landau, D., R. Eshet, A. Troib, Y. Gurman, Y. Chen, R. Rabkin, and Y. Segev. 2009. Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation. Endocrine 36: 126-134.
16. Rawlings, J. S., M. Gatzka, P. G. Thomas, and J. N. Ihle. 2011. Chromatin condensation via the condensin II complex is required for peripheral T-cell quiescence. EMBO J. 30: 263-276.
17. Clarke, D. L., A. Sutcliffe, K. Deacon, D. Bradbury, L. Corbett, and A. J. Knox. 2008. PKCbII augments NF-κB-dependent transcription at the CCL11 promoter via p300/CBP-associated factor recruitment and histone H4 acetylation. J. Immunol. 181: 3503-3514.
18. Gorentla, B. K., and X. P. Zhong. 2012. T cell receptor signal transduction in T lymphocytes. J. Clin. Cell Immunol. 2012(Suppl. 12): 5.
19. Heissmeyer, V., F. Macián, S. H. Im, R. Varma, S. Feske, K. Venuprasad, H. Gu, Y. C. Liu, M. L. Dustin, and A. Rao. 2004. Calcineurin imposes T cell unre-sponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5: 255-265.
20. Miao, F., D. D. Smith, L. Zhang, A. Min, W. Feng, and R. Natarajan. 2008. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 57: 3189-3198.
21. Villeneuve, L. M., and R. Natarajan. 2010. The role of epigenetics in the pathology of diabetic complications. Am. J. Physiol. Renal Physiol. 299: F14-F25.
22. Ceriello, A., M. A. Ihnat, and J. E. Thorpe. 2009. Clinical review 2: the "metabolic memory" - is more than just tight glucose control necessary to prevent diabetic complications? J. Clin. Endocrinol. Metab. 94: 410-415.
23. Donskoy, E., D. Foss, and I. Goldschneider. 2003. Gated importation of pro-thymocytes by adult mouse thymus is coordinated with their periodic mobilization from bone marrow. J. Immunol. 171: 3568-3575.
24. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.
25. Di Rosa, F., and R. Pabst. 2005. The bone marrow: a nest for migratory memory T cells. Trends Immunol. 26: 360-366.
26. Yamamoto, Y., and H. Yamamoto. 2013. RAGE-mediated inflammation, type 2 diabetes, and diabetic vascular complication. Front. Endocrinol. (Lausanne) 4: 105.
27. Martinez, N., and H. Kornfeld. 2014. Diabetes and immunity to tuberculosis. Eur. J. Immunol. 44: 617-626.
28. Nguyen, D. V., L. C. Shaw, and M. B. Grant. 2012. Inflammation in the pathogenesis of microvascular complications in diabetes. Front. Endocrinol. (Lausanne) 3: 170.
29. Krisp, C., F. Jacobsen, M. J. McKay, M. P. Molloy, L. Steinstraesser, and D. A. Wolters. 2013. Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients. Proteomics 13: 2670-2681.
30. Surendar, J., V. Mohan, M. M. Rao, S. Babu, and V. Aravindhan. 2011. Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103). Diabetes Technol. Ther. 13: 477-482.
31. Fuentes, M. K., S. S. Nigavekar, T. Arumugam, C. D. Logsdon, A. M. Schmidt, J. C. Park, and E. H. Huang. 2007. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis. Colon Rectum 50: 1230-1240.
32. Reddy, M. A., S. L. Li, S. Sahar, Y. S. Kim, Z. G. Xu, L. Lanting, and R. Natarajan. 2006. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J. Biol. Chem. 281: 13685-13693.
33. Fang, F., L. F. Lue, S. Yan, H. Xu, J. S. Luddy, D. Chen, D. G. Walker, D. M. Stern, S. Yan, A. M. Schmidt, et al. 2010. RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEBJ. 24: 1043-1055.
34. Xu, X., H. Chen, X. Zhu, Y. Ma, Q. Liu, Y. Xue, H. Chu, W. Wu, J. Wang, and H. Zou. 2013. S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways. Clin. Exp. Immunol. 173: 523-535.
35. Liu, Y., C. Liang, X. Liu, B. Liao, X. Pan, Y. Ren, M. Fan, M. Li, Z. He, J. Wu, and Z. Wu. 2010. AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-κB pathways. Atherosclerosis 208: 34-42.
36. Sparvero, L. J., D. Asafu-Adjei, R. Kang, D. Tang, N. Amin, J. Im, R. Rutledge, B. Lin, A. A. Amoscato, H. J. Zeh, and M. T. Lotze. 2009. RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med. 7: 17.
37. Wang, Q. E., C. Han, R. Zhao, G. Wani, Q. Zhu, L. Gong, A. Battu, I. Racoma, N. Sharma, and A. A. Wani. 2013. p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair. Nucleic Acids Res. 41: 1722-1733.
38. Sheppard, K. A., D. W. Rose, Z. K. Haque, R. Kurokawa, E. McInerney, S. Westin, D. Thanos, M. G. Rosenfeld, C. K. Glass, and T. Collins. 1999. Transcriptional activation by NF-κB requires multiple coactivators. Mol. Cell. Biol. 19: 6367-6378.
39. Szerlong, H. J., J. E. Prenni, J. K. Nyborg, and J. C. Hansen. 2010. Activator-dependent p300 acetylation of chromatin in vitro: enhancement of transcription by disruption of repressive nucleosome-nucleosome interactions. J. Biol. Chem. 285: 31954-31964.
40. Rainger, J. K., S. Bhatia, H. Bengani, P. Gautier, J. Rainger, M. Pearson, M. Ansari, J. Crow, F. Mehendale, B. Palinkasova, et al. 2014. Disruption of SATB2 or its long-range cis-regulation by SOX9 causes a syndromic form of Pierre Robin sequence. Hum. Mol. Genet. 23: 2569-2579.
41. + T cells. Mol. Cell. Biol. 20: 936-946.
42. Föger, N., R. Marhaba, and M. Zöller. 2000. CD44 supports T cell proliferation and apoptosis by apposition of protein kinases. Eur. J. Immunol. 30: 2888-2899.
43. Akirav, E. M., P. Preston-Hurlburt, J. Garyu, O. Henegariu, R. Clynes, A. M. Schmidt, and K. C. Herold. 2012. RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. PLoS ONE 7: e34698.
44. Giacco, F., and M. Brownlee. 2010. Oxidative stress and diabetic complications. Circ. Res. 107: 1058-1070.